Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate-leucovorin in patients with advanced squamous carcinoma of the head and neck: a safe new effective regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples